Osteoporosis, Postmenopausal
Pipeline by Development Stage
Drug Modality Breakdown
On Market (1)
Approved therapies currently available
Competitive Landscape
16 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 34 trials with date data
Clinical Trials (35)
Total enrollment: 63,801 patients across 35 trials
Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone
Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopausal Women
A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide
Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis
A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis
2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis
Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis
Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis
Comparative Efficacy, Safety, PK, and Immunogenicity Study
Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND
Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption
Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis
Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis
Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer
Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis
Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis
Effect of Blueberries on Bone Turnover
A Clinical Trial to Evaluate the Safety and Pharmacokinetic
A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal Women
A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants
A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women
The Effect of the Probiotic Strains on Bone Mineral Density in Postmenopausal Women
Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women
Bindex for Osteoporosis Diagnostics
Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes
Soluble Corn Fiber Effect on Bone Resorption in Post Menopausal Women
Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)
Hesperidin and Bone Health in Postmenopausal Women
The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women
Wellnara Post-marketing Surveillance in Japan
Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan
Julina Post-marketing Surveillance for Climacteric Symptoms in Japan
A Study for Teriparatide in Severe Osteoporosis
Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.